AbbVie Presents Encouraging Phase 1 Data for Investigational Medicine ABT-414 as Monotherapy in Patients with an Aggressive Brain Cancer at the 2016 American Society of Clinical Oncology Annual Meeting

… with malignant GBM, an aggressive brain cancer.
[2]
As of January 7 … and most aggressive form of brain cancer,
[4]
have a median survival … treatment options for this devastating brain cancer," said Martin van den …